GLP-1 Coverage & Costs in Illinois (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Illinois at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
Illinois Medicaid Coverage for GLP-1
Medicaid: not covered as of January 2026 (KFF)
KFF's map lists Illinois as not covering GLP-1s for obesity under fee-for-service as of January 2026. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
Your Options in Illinois:
- Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves Illinois
- Commercial or employer insurance: check your plan's drug list and prior authorization rules
- Medicare GLP-1 Bridge for eligible Part D enrollees (see below)
Illinois Medicaid GLP-1 Prescriptions in 2025
288,470
#9
$300.8 million
Trulicity
Illinois Medicaid paid for 288,470 GLP-1 prescriptions in 2025, 2.6% of the 11.26 million paid nationally and number 9 of 51 (50 states and DC). It reimbursed pharmacies $300.8 million before manufacturer rebates, about $1,043 per prescription, and the most-filled product was Trulicity. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 3,046 of those prescriptions (1.1%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, Illinois Medicaid GLP-1 prescriptions went from 91,294 to 288,470, 3.2 times the 2021 count. From 2024 to 2025 the count rose by 23,575.
91,294
174,283
267,641
264,895
288,470
| Product | IL Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Trulicity | 178,820 | 62% |
| Mounjaro | 34,435 | 11.9% |
| Ozempic | 30,556 | 10.6% |
| Rybelsus | 23,662 | 8.2% |
| Liraglutide (generic) | 16,514 | 5.7% |
| Zepbound | 1,937 | 0.7% |
| Victoza | 1,417 | 0.5% |
| Wegovy | 1,109 | 0.4% |
| Bydureon | 20 | under 0.1% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
Illinois Employee Plan and Insurer GLP-1 Rules
Illinois State Employees Group Insurance Program
Covers with limitsIllinois state employee plans cover medically necessary injectable medication for weight loss for adults with prediabetes, gestational diabetes or obesity, under state law. After the first prescription the member must enroll in, and stay in, a lifestyle management program or coverage is denied.
Central Management Services says all plans in the program cover injectable weight-loss medication for adults with prediabetes, gestational diabetes or obesity.
“all health plans under the State Employees Group Insurance Program will provide coverage for all types of medically necessary injectable medication prescribed to improve glucose or weight loss for use by adults (age 18 and over) that have been diagnosed with prediabetes, gestational diabetes, or obesity.”
Source: Illinois Department of Central Management Services. Read October 29, 2026.
Coverage depends on enrolling in the plan's lifestyle management program.
“If you fail to enroll or continue to participate in the LMP, future coverage will be denied.”
Source: Illinois Department of Central Management Services. Read October 29, 2026.
Blue Cross and Blue Shield of Illinois
Covers with limitsBlue Cross and Blue Shield of Illinois treats GLP-1 weight-management coverage as an optional choice for employer groups. From November 1, 2026, self-funded groups with Prime Therapeutics that cover these drugs can set a $150 member cost share for up to a 30-day supply.
In a May 20, 2026 note for self-funded groups, Blue Cross and Blue Shield of Illinois says GLP-1 weight-management coverage is optional for the plan.
“As with other GLP‑1s for weight management, plan coverage is optional with utilization management and metabolic health programs are available to drive safe and clinically appropriate use.”
Source: Blue Cross and Blue Shield of Illinois. Read October 29, 2026.
An October 9, 2026 employer notice adds a $150 member cost-share option from November 1, 2026 for self-funded groups that cover these drugs.
“Beginning Nov. 1, 2026, self-funded groups with Prime Therapeutics® that cover GLP-1 weight-management drugs can elect a new, $150 member cost-share benefit.”
Source: Blue Cross and Blue Shield of Illinois. Read October 29, 2026.
Comparing self-pay programs in Illinois?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for Illinois
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Illinois. The rest record a state count without naming the states, so confirm Illinois with the program at intake before you pay.
What Programs' Own Pages Say About Illinois
8 of the 8 programs whose own pages name the states they serve include Illinois: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | Illinois |
|---|---|
| Willow | Serves IL |
| SnagRx | Serves IL |
| Strut Health | Ships to IL |
| MangoRx | Ships to IL |
| Wellorithm | Serves IL |
| MEDGm | Serves IL |
| TelosRx | Serves IL |
| Trimi | Serves IL |
Trimi's state table lists Illinois as served through the Arora Health network. Visit format there: Online intake reviewed by a licensed provider; no in-person visit required. The telehealth law it cites for Illinois is 225 ILCS 150/5 and 150/15 (Telehealth Act). That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in Illinois
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in Illinois, 2024
Illinois prescribers wrote 702,606 Medicare Part D GLP-1 claims in 2024, number 10 of 51, with $909.5 million in gross drug cost before rebates. Ozempic led with 337,317 claims for 66,633 enrollees. Wegovy had 9,030 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | IL Part D claims | Enrollees |
|---|---|---|
| Ozempic | 337,317 | 66,633 |
| Trulicity | 145,277 | 28,243 |
| Mounjaro | 143,036 | 27,174 |
| Rybelsus | 49,687 | 12,724 |
| Victoza | 10,343 | Not given |
| Wegovy | 9,030 | 2,256 |
| Bydureon Bcise | 6,246 | 1,339 |
| Liraglutide | 1,343 | 619 |
| Byetta | 327 | 85 |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in Illinois
The Bridge is national, so the rules are the same in Illinois as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How Illinois Compares to Other Midwest States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Illinois and its neighbors in the Midwest are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| Illinois (this page) | Not covered | 288,470 |
| Indiana | Not covered | 190,013 |
| Iowa | Not covered | 88,518 |
| Kansas | Covered, January 2026 (KFF) | 50,850 |
| Michigan | Covered, January 2026 (KFF) | 607,982 |
| Minnesota | Covered, January 2026 (KFF) | 230,594 |
| Missouri | Covered, January 2026 (KFF) | 285,105 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
GLP-1 Guides for Illinois Cities
If Your Insurance Denies GLP-1 Coverage in Illinois
Commercial plans offer an internal appeal, then external review; Illinois Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in Illinois
- Illinois Medicaid: Medicaid: not covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: Illinois State Employees Group Insurance Program, covers with limits per the documents cited above. Confirm with the plan before you fill a prescription.
- Insurers on record for Illinois: Blue Cross and Blue Shield of Illinois. Each still depends on whether your employer bought the weight-loss benefit.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in Illinois
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Illinois.
Frequently Asked Questions — Illinois
Does Illinois Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did Illinois Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in Illinois in 2024?
Does the Illinois state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in Illinois?
Which online GLP-1 programs serve Illinois?
Does Medicare cover GLP-1s in Illinois?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.